[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![USCorpFilings Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::1859110030752313345.png) SEC Filings Digest [@USCorpFilings](/creator/twitter/USCorpFilings) on x 4373 followers
Created: 2025-07-01 21:00:07 UTC

$DYN Equity Offerings:

On June 30, 2025, Dyne Therapeutics, Inc. announced an underwritten public offering of XXXXXXXXXX shares at $XXXX each, expected to generate approximately $XXX million in net proceeds, which will support operations through Q3 2027.




XXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1940153468401901812/c:line.svg)

**Related Topics**
[stocks](/topic/stocks)
[primary market](/topic/primary-market)
[$dyn](/topic/$dyn)
[sec](/topic/sec)
[dyne therapeutics](/topic/dyne-therapeutics)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/USCorpFilings/status/1940153468401901812)